Measuring the gains from medical research : an economic approach
著者
書誌事項
Measuring the gains from medical research : an economic approach
University of Chicago Press, 2003
大学図書館所蔵 全12件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and indexes
収録内容
- The health of nations : the contribution of improved health to living standards / William D. Nordhaus
- The economic value of medical research / Kevin M. Murphy and Robert H. Topel
- Pharmaceutical innovation, mortality reduction, and economic growth / Frank R. Lichtenberg
- The return to biomedical research : treatment and behavioral effects / David M. Cutler and Srikanth Kadiyala
- Biomedical research and then some : the causes of technological change in heart attack treatment / Paul Heidenreich and Mark McClellan
- Can medical cost-effectiveness analysis identify the value of research? / David Meltzer
内容説明・目次
内容説明
In 1998, health expenditures in the United States accounted for 12.9% of national income - the highest share of income devoted to health in the developed world. The United States also spends more on medical research than any other country - in 2000, the federal government decicated $18.4 billion to it, compared to only $3.7 billion for the entire European Union. In this book, leading health economists ask whether we are getting our money's worth. From an economic perspective, they find, the answer is a resounding "yes"; in fact considering the extraordinary value of improvements to health, we may even be spending "too little" on medical research. The evidence these papers present and the conclusions they reach are surprising and convincing: among them, that growth in longevity since 1950 has been as valuable as growth in all other forms of consumption combined; that medical advances producing 10% reductions in mortality from cancer and heart disease alone would add roughly $10 trillion (a year's GDP) to national wealth; and that the average new drug approved by the FDA yields benefits worth many times its costs of development.
For anyone concerned about the cost and value of medical research, from policymakers to health care professionals and economists, this should be a landmark book.
「Nielsen BookData」 より